UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains

Alzheimer's research & therapy, 2015-08, Vol.7 (1), p.56-56, Article 56

2015

Volltextzugriff (PDF)

TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices

Brain pathology (Zurich, Switzerland), 2015-07, Vol.25 (4), p.469-480

2015

Volltextzugriff (PDF)

Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer's Disease Brains

International journal of molecular sciences, 2020-01, Vol.21 (2), p.678

2020

Volltextzugriff (PDF)

Studies on Colony Stimulating Factor Receptor-1 and Ligands Colony Stimulating Factor-1 and Interleukin-34 in Alzheimer's Disease Brains and Human Microglia

Frontiers in aging neuroscience, 2017-08, Vol.9, p.244-244

2017

Volltextzugriff (PDF)

Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammation

Experimental neurology, 2009-01, Vol.215 (1), p.5-19

2009

Volltextzugriff (PDF)

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies

Neurology and therapy, 2017-07, Vol.6 (S1), p.25-36

2017

Volltextzugriff (PDF)

Microglia Activation and Anti-inflammatory Regulation in Alzheimer's Disease

Molecular neurobiology, 2010-06, Vol.41 (2-3), p.115-128

2010

Volltextzugriff (PDF)

Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway

Neurobiology of disease, 2009-04, Vol.34 (1), p.95-106

2009

Volltextzugriff (PDF)

Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer's Dementia: Findings in Two Cohorts

Frontiers in aging neuroscience, 2017-07, Vol.9, p.226-226

2017

Volltextzugriff (PDF)

Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production

Neurobiology of disease, 2008-03, Vol.29 (3), p.422-437

2008

Volltextzugriff (PDF)

Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID Technology

Neurology and therapy, 2019-12, Vol.8 (Suppl 2), p.95-111

2019

Volltextzugriff (PDF)

Alzheimer's Disease Research Using Human Microglia

Cells (Basel, Switzerland), 2019-08, Vol.8 (8), p.838

2019

Volltextzugriff (PDF)

Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer's disease and aged brains: increased levels correlate with neuropathology

Acta neuropathologica communications, 2019-12, Vol.7 (1), p.215-215, Article 215

2019

Volltextzugriff (PDF)

Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal Subjects

Frontiers in aging neuroscience, 2019-09, Vol.11, p.222-222

2019

Volltextzugriff (PDF)

Understanding the Neurobiology of Cd200 and the Cd200 Receptor: A Therapeutic Target For Controlling Inflammation In Human Brains?

Future neurology, 2013-05, Vol.8 (3), p.321-332

2013

Volltextzugriff (PDF)

RAGE potentiates Aβ-induced perturbation of neuronal function in transgenic mice

The EMBO journal, 2004-10, Vol.23 (20), p.4096-4105

2004

Volltextzugriff (PDF)

RAGE: A Potential Target for Aβ-Mediated Cellular Perturbation in Alzheimers Disease

Current molecular medicine, 2007-12, Vol.7 (8), p.735-742

2007

Volltextzugriff (PDF)

Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases

Frontiers in neuroscience, 2016-01, Vol.9, p.507-507

2016

Volltextzugriff (PDF)

ASSESSING POTENTIALS OF PLASMA AMYLOID BETA 42 AND TAU LEVELS FOR ALZHEIMER'S DISEASE DIAGNOSIS BY TESTING IMMUNOMAGNETIC REDUCTION TECHNOLOGY IN A SUN CITY COHORT

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P1515-P1515

2017

Volltextzugriff (PDF)

Anti-inflammatory and Immune Therapy for Alzheimers Disease: Current Status and Future Directions

Current neuropharmacology, 2007-12, Vol.5 (4), p.232-243

2007

Volltextzugriff (PDF)

Long-Term Storage Effects on Stability of Aβ1–40, Aβ1–42, and Total Tau Proteins in Human Plasma Samples Measured with Immunomagnetic Reduction Assays

Dementia and geriatric cognitive disorders extra, 2019-02, Vol.9 (1), p.77-86

2019

Volltextzugriff (PDF)

Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model

Biochimica et biophysica acta, 2012-02, Vol.1822 (2), p.286-292

2012

Volltextzugriff (PDF)

ABCG2 Is Upregulated in Alzheimer's Brain with Cerebral Amyloid Angiopathy and May Act as a Gatekeeper at the Blood–Brain Barrier for Aβ 1–40 Peptides

The Journal of neuroscience, 2009-04, Vol.29 (17), p.5463-5475

2009

Volltextzugriff (PDF)

Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease

Journal of neuroinflammation, 2006-10, Vol.3 (1), p.28-28, Article 28

2006

Volltextzugriff (PDF)

CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid β‐peptide

European journal of immunology, 2005-03, Vol.35 (3), p.901-910

2005

Volltextzugriff (PDF)

1 – 25 von 131

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(117)

Publikationsform

Sprache

Englisch
(131)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains

TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices

Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer's Disease Brains

Studies on Colony Stimulating Factor Receptor-1 and Ligands Colony Stimulating Factor-1 and Interleukin-34 in Alzheimer's Disease Brains and Human Microglia

Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammation

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies

Microglia Activation and Anti-inflammatory Regulation in Alzheimer's Disease

Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway

Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer's Dementia: Findings in Two Cohorts

Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production

Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID Technology

Alzheimer's Disease Research Using Human Microglia

Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer's disease and aged brains: increased levels correlate with neuropathology

Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal Subjects

Understanding the Neurobiology of Cd200 and the Cd200 Receptor: A Therapeutic Target For Controlling Inflammation In Human Brains?

RAGE potentiates Aβ-induced perturbation of neuronal function in transgenic mice

RAGE: A Potential Target for Aβ-Mediated Cellular Perturbation in Alzheimers Disease

Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases

ASSESSING POTENTIALS OF PLASMA AMYLOID BETA 42 AND TAU LEVELS FOR ALZHEIMER'S DISEASE DIAGNOSIS BY TESTING IMMUNOMAGNETIC REDUCTION TECHNOLOGY IN A SUN CITY COHORT

Anti-inflammatory and Immune Therapy for Alzheimers Disease: Current Status and Future Directions

Long-Term Storage Effects on Stability of Aβ1–40, Aβ1–42, and Total Tau Proteins in Human Plasma Samples Measured with Immunomagnetic Reduction Assays

Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model

ABCG2 Is Upregulated in Alzheimer's Brain with Cerebral Amyloid Angiopathy and May Act as a Gatekeeper at the Blood–Brain Barrier for Aβ 1–40 Peptides

Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease

CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid β‐peptide

Aktive Filter

Suchergebnisse filtern